German contribution to development and innovations in the management of acute myocardial infarction and cardiogenic shock

[1]  T. Friede,et al.  Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial , 2018, European heart journal.

[2]  Marco Valgimigli,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[3]  J. Wald,et al.  Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States , 2018, Clinical Research in Cardiology.

[4]  H. Thiele,et al.  Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials , 2017, European heart journal.

[5]  E. Ohman,et al.  Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials , 2017, European heart journal.

[6]  Dorin Comaniciu,et al.  Early diagnosis of acute coronary syndrome , 2017, European heart journal.

[7]  H. Thiele,et al.  PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock , 2017, The New England journal of medicine.

[8]  E. Vicaut,et al.  Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials , 2017, The Lancet.

[9]  G. Schuler,et al.  MILD HYPOTHERMIA IN CARDIOGENIC SHOCK COMPLICATING MYOCARDIAL INFARCTION: THE RANDOMIZED SHOCK-COOL PILOT TRIAL , 2017 .

[10]  G. Schuler,et al.  Thrombus aspiration in non-ST-elevation myocardial infarction – 12-month clinical outcome of the randomised TATORT-NSTEMI trial , 2017, European heart journal. Acute cardiovascular care.

[11]  R. Erbel,et al.  Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i. v. and 300 mg p. o. in ACS (ACUTE) , 2017, Thrombosis and Haemostasis.

[12]  S. Yusuf,et al.  Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration. , 2017, Circulation.

[13]  S. Yusuf,et al.  Thrombus Aspiration in ST Elevation Myocardial Infarction : An Individual Patient Meta-analysis Running , 2016 .

[14]  G. Schuler,et al.  Outcome of elderly undergoing extracorporeal life support in refractory cardiogenic shock , 2017, Clinical Research in Cardiology.

[15]  B. D. de Mol,et al.  Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis , 2016, Intensive Care Medicine.

[16]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.

[17]  G. Schuler,et al.  Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial. , 2015, European heart journal.

[18]  E. Ohman,et al.  Management of cardiogenic shock. , 2015, European heart journal.

[19]  H. Schunkert,et al.  Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials , 2015, Clinical Research in Cardiology.

[20]  Holger Thiele,et al.  Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. , 2014, Journal of the American College of Cardiology.

[21]  G. Schuler,et al.  Effect of aspiration thrombectomy on microvascular obstruction in NSTEMI patients: the TATORT-NSTEMI trial. , 2014, Journal of the American College of Cardiology.

[22]  C. Di Mario,et al.  Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. , 2014, European heart journal.

[23]  G. Montalescot,et al.  Prehospital ticagrelor in ST-segment elevation myocardial infarction. , 2014, The New England journal of medicine.

[24]  G. Schuler,et al.  Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial , 2013, The Lancet.

[25]  G. Schuler,et al.  Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial. , 2013, Journal of the American College of Cardiology.

[26]  N. Parakh.  Intraaortic balloon support for myocardial infarction with cardiogenic shock , 2012 .

[27]  G. Schuler,et al.  Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). , 2012, European heart journal.

[28]  G. Schuler,et al.  Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial , 2012, The Lancet.

[29]  L. Newby,et al.  Post-myocardial infarction cardiogenic shock is a systemic illness in need of systemic treatment: is therapeutic hypothermia one possibility? , 2012, Journal of the American College of Cardiology.

[30]  K. Huber,et al.  Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial , 2012, Clinical Research in Cardiology.

[31]  S. Blankenberg,et al.  Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. , 2011, JAMA.

[32]  Jörg Hausleiter,et al.  Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. , 2011, The New England journal of medicine.

[33]  A. Macas,et al.  Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock. , 2011, Medicina.

[34]  C. Bode,et al.  Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial. , 2010, Journal of the American College of Cardiology.

[35]  G. Schuler,et al.  IMPACT OF EARLY VERSUS LATE MICROVASCULAR OBSTRUCTION ASSESSED BY MAGNETIC RESONANCE IMAGING ON LONG-TERM OUTCOME AFTER ST-ELEVATION MYOCARDIAL INFARCTION , 2010 .

[36]  Stefan Blankenberg,et al.  Sensitive troponin I assay in early diagnosis of acute myocardial infarction. , 2009, The New England journal of medicine.

[37]  S. Yusuf,et al.  Early versus delayed invasive intervention in acute coronary syndromes. , 2009, The New England journal of medicine.

[38]  F. Burzotta,et al.  Myocardial no-reflow in humans. , 2009, Journal of the American College of Cardiology.

[39]  H. White,et al.  Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. , 2006, JAMA.

[40]  R. Schröder.  Prognostic Impact of Early ST-Segment Resolution in Acute ST-Elevation Myocardial Infarction , 2004, Circulation.

[41]  U. Zeymer,et al.  Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI): Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK) , 2004 .

[42]  S. Nekolla,et al.  Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. , 2002, Lancet.

[43]  H. Suryapranata,et al.  The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. , 2001, Journal of the American College of Cardiology.

[44]  K. Wegscheider,et al.  Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction , 2001, The Lancet.

[45]  M. Schwaiger,et al.  Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. , 2000, The New England journal of medicine.

[46]  oldmann,et al.  EMERGENCY ROOM TRIAGE OF PATIENTS WITH ACUTE CHEST PAIN BY MEANS OF RAPID TESTING FOR CARDIAC TROPONIN T OR TROPONIN I , 2000 .

[47]  J. Ottervanger,et al.  Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. , 1999, The New England journal of medicine.

[48]  H. White,et al.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.

[49]  C. Heeschen,et al.  Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. , 1999, The New England journal of medicine.

[50]  J O'Keefe,et al.  A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .

[51]  W. Dassen,et al.  Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis. , 1990, Journal of the American College of Cardiology.